| UniProt ID | MED13_HUMAN | |
|---|---|---|
| UniProt AC | Q9UHV7 | |
| Protein Name | Mediator of RNA polymerase II transcription subunit 13 | |
| Gene Name | MED13 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 2174 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.. | |
| Protein Sequence | MSASFVPNGASLEDCHCNLFCLADLTGIKWKKYVWQGPTSAPILFPVTEEDPILSSFSRCLKADVLGVWRRDQRPGRRELWIFWWGEDPSFADLIHHDLSEEEDGVWENGLSYECRTLLFKAVHNLLERCLMNRNFVRIGKWFVKPYEKDEKPINKSEHLSCSFTFFLHGDSNVCTSVEINQHQPVYLLSEEHITLAQQSNSPFQVILCPFGLNGTLTGQAFKMSDSATKKLIGEWKQFYPISCCLKEMSEEKQEDMDWEDDSLAAVEVLVAGVRMIYPACFVLVPQSDIPTPSPVGSTHCSSSCLGVHQVPASTRDPAMSSVTLTPPTSPEEVQTVDPQSVQKWVKFSSVSDGFNSDSTSHHGGKIPRKLANHVVDRVWQECNMNRAQNKRKYSASSGGLCEEATAAKVASWDFVEATQRTNCSCLRHKNLKSRNAGQQGQAPSLGQQQQILPKHKTNEKQEKSEKPQKRPLTPFHHRVSVSDDVGMDADSASQRLVISAPDSQVRFSNIRTNDVAKTPQMHGTEMANSPQPPPLSPHPCDVVDEGVTKTPSTPQSQHFYQMPTPDPLVPSKPMEDRIDSLSQSFPPQYQEAVEPTVYVGTAVNLEEDEANIAWKYYKFPKKKDVEFLPPQLPSDKFKDDPVGPFGQESVTSVTELMVQCKKPLKVSDELVQQYQIKNQCLSAIASDAEQEPKIDPYAFVEGDEEFLFPDKKDRQNSEREAGKKHKVEDGTSSVTVLSHEEDAMSLFSPSIKQDAPRPTSHARPPSTSLIYDSDLAVSYTDLDNLFNSDEDELTPGSKKSANGSDDKASCKESKTGNLDPLSCISTADLHKMYPTPPSLEQHIMGFSPMNMNNKEYGSMDTTPGGTVLEGNSSSIGAQFKIEVDEGFCSPKPSEIKDFSYVYKPENCQILVGCSMFAPLKTLPSQYLPPIKLPEECIYRQSWTVGKLELLSSGPSMPFIKEGDGSNMDQEYGTAYTPQTHTSFGMPPSSAPPSNSGAGILPSPSTPRFPTPRTPRTPRTPRGAGGPASAQGSVKYENSDLYSPASTPSTCRPLNSVEPATVPSIPEAHSLYVNLILSESVMNLFKDCNFDSCCICVCNMNIKGADVGVYIPDPTQEAQYRCTCGFSAVMNRKFGNNSGLFLEDELDIIGRNTDCGKEAEKRFEALRATSAEHVNGGLKESEKLSDDLILLLQDQCTNLFSPFGAADQDPFPKSGVISNWVRVEERDCCNDCYLALEHGRQFMDNMSGGKVDEALVKSSCLHPWSKRNDVSMQCSQDILRMLLSLQPVLQDAIQKKRTVRPWGVQGPLTWQQFHKMAGRGSYGTDESPEPLPIPTFLLGYDYDYLVLSPFALPYWERLMLEPYGSQRDIAYVVLCPENEALLNGAKSFFRDLTAIYESCRLGQHRPVSRLLTDGIMRVGSTASKKLSEKLVAEWFSQAADGNNEAFSKLKLYAQVCRYDLGPYLASLPLDSSLLSQPNLVAPTSQSLITPPQMTNTGNANTPSATLASAASSTMTVTSGVAISTSVATANSTLTTASTSSSSSSNLNSGVSSNKLPSFPPFGSMNSNAAGSMSTQANTVQSGQLGGQQTSALQTAGISGESSSLPTQPHPDVSESTMDRDKVGIPTDGDSHAVTYPPAIVVYIIDPFTYENTDESTNSSSVWTLGLLRCFLEMVQTLPPHIKSTVSVQIIPCQYLLQPVKHEDREIYPQHLKSLAFSAFTQCRRPLPTSTNVKTLTGFGPGLAMETALRSPDRPECIRLYAPPFILAPVKDKQTELGETFGEAGQKYNVLFVGYCLSHDQRWILASCTDLYGELLETCIINIDVPNRARRKKSSARKFGLQKLWEWCLGLVQMSSLPWRVVIGRLGRIGHGELKDWSCLLSRRNLQSLSKRLKDMCRMCGISAADSPSILSACLVAMEPQGSFVIMPDSVSTGSVFGRSTTLNMQTSQLNTPQDTSCTHILVFPTSASVQVASATYTTENLDLAFNPNNDGADGMGIFDLLDTGDDLDPDIINILPASPTGSPVHSPGSHYPHGGDAGKGQSTDRLLSTEPHEEVPNILQQPLALGYFVSTAKAGPLPDWFWSACPQAQYQCPLFLKASLHLHVPSVQSDELLHSKHSHPLDSNQTSDVLRFVLEQYNALSWLTCDPATQDRRSCLPIHFVVLNQLYNFIMNML | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 56 | Phosphorylation | EEDPILSSFSRCLKA CCCCHHHHHHHHHHC | 24.64 | 24945436 | |
| 70 | Methylation | ADVLGVWRRDQRPGR CHHHEEEECCCCCCC | 29.86 | 54560319 | |
| 225 | O-linked_Glycosylation | TGQAFKMSDSATKKL CCCEEECCHHHHHHH | 29.07 | 30379171 | |
| 227 | O-linked_Glycosylation | QAFKMSDSATKKLIG CEEECCHHHHHHHHH | 30.45 | 30379171 | |
| 229 | O-linked_Glycosylation | FKMSDSATKKLIGEW EECCHHHHHHHHHHH | 32.44 | 30379171 | |
| 237 | Acetylation | KKLIGEWKQFYPISC HHHHHHHHHHHHHHH | 26.65 | 26051181 | |
| 240 | Phosphorylation | IGEWKQFYPISCCLK HHHHHHHHHHHHHHH | 9.36 | - | |
| 243 | Phosphorylation | WKQFYPISCCLKEMS HHHHHHHHHHHHHCC | 8.35 | - | |
| 321 | Phosphorylation | STRDPAMSSVTLTPP CCCCCCCCEEEECCC | 24.62 | 30108239 | |
| 322 | Phosphorylation | TRDPAMSSVTLTPPT CCCCCCCEEEECCCC | 13.16 | 30108239 | |
| 324 | Phosphorylation | DPAMSSVTLTPPTSP CCCCCEEEECCCCCH | 27.19 | 30266825 | |
| 326 | Phosphorylation | AMSSVTLTPPTSPEE CCCEEEECCCCCHHH | 20.18 | 30266825 | |
| 329 | Phosphorylation | SVTLTPPTSPEEVQT EEEECCCCCHHHHCC | 59.11 | 30266825 | |
| 330 | Phosphorylation | VTLTPPTSPEEVQTV EEECCCCCHHHHCCC | 35.77 | 30266825 | |
| 336 | Phosphorylation | TSPEEVQTVDPQSVQ CCHHHHCCCCHHHHH | 31.86 | 30266825 | |
| 341 | Phosphorylation | VQTVDPQSVQKWVKF HCCCCHHHHHHHEEC | 31.72 | 30108239 | |
| 349 | Phosphorylation | VQKWVKFSSVSDGFN HHHHEECCCCCCCCC | 24.90 | - | |
| 366 | Acetylation | STSHHGGKIPRKLAN CCCCCCCCCCHHHHH | 54.88 | 25953088 | |
| 366 | Ubiquitination | STSHHGGKIPRKLAN CCCCCCCCCCHHHHH | 54.88 | - | |
| 394 | Phosphorylation | RAQNKRKYSASSGGL HHHHCCCCCCCCCCC | 17.32 | 30266825 | |
| 395 | Phosphorylation | AQNKRKYSASSGGLC HHHCCCCCCCCCCCC | 25.39 | 23401153 | |
| 397 | Phosphorylation | NKRKYSASSGGLCEE HCCCCCCCCCCCCHH | 24.47 | 30266825 | |
| 398 | Phosphorylation | KRKYSASSGGLCEEA CCCCCCCCCCCCHHH | 36.27 | 30266825 | |
| 406 | Phosphorylation | GGLCEEATAAKVASW CCCCHHHHHHHHHCC | 30.35 | 23927012 | |
| 445 | Phosphorylation | GQQGQAPSLGQQQQI CCCCCCCCHHHHHHH | 48.42 | 28555341 | |
| 474 | Phosphorylation | KPQKRPLTPFHHRVS CCCCCCCCCCCCCCC | 26.96 | 30266825 | |
| 481 | Phosphorylation | TPFHHRVSVSDDVGM CCCCCCCCCCCCCCC | 18.83 | 23911959 | |
| 483 | Phosphorylation | FHHRVSVSDDVGMDA CCCCCCCCCCCCCCC | 22.16 | 25850435 | |
| 494 | Phosphorylation | GMDADSASQRLVISA CCCCCCHHCEEEEEC | 21.56 | 27251275 | |
| 500 | Phosphorylation | ASQRLVISAPDSQVR HHCEEEEECCCCCEE | 26.69 | 25159151 | |
| 504 | Phosphorylation | LVISAPDSQVRFSNI EEEECCCCCEEECCC | 29.52 | 25159151 | |
| 513 | Phosphorylation | VRFSNIRTNDVAKTP EEECCCCCCCCCCCC | 31.79 | 28985074 | |
| 519 | Phosphorylation | RTNDVAKTPQMHGTE CCCCCCCCCCCCCCC | 14.71 | 23927012 | |
| 525 | Phosphorylation | KTPQMHGTEMANSPQ CCCCCCCCCCCCCCC | 14.12 | 23927012 | |
| 530 | Phosphorylation | HGTEMANSPQPPPLS CCCCCCCCCCCCCCC | 18.51 | 23401153 | |
| 537 | Phosphorylation | SPQPPPLSPHPCDVV CCCCCCCCCCCCCCC | 27.26 | 23401153 | |
| 549 | Phosphorylation | DVVDEGVTKTPSTPQ CCCCCCCCCCCCCCC | 39.80 | 23663014 | |
| 551 | Phosphorylation | VDEGVTKTPSTPQSQ CCCCCCCCCCCCCHH | 17.07 | 25159151 | |
| 553 | Phosphorylation | EGVTKTPSTPQSQHF CCCCCCCCCCCHHCC | 58.93 | 20068231 | |
| 554 | Phosphorylation | GVTKTPSTPQSQHFY CCCCCCCCCCHHCCC | 26.93 | 25849741 | |
| 557 | Phosphorylation | KTPSTPQSQHFYQMP CCCCCCCHHCCCCCC | 27.16 | 20068231 | |
| 561 | Phosphorylation | TPQSQHFYQMPTPDP CCCHHCCCCCCCCCC | 11.19 | 20068231 | |
| 565 | Phosphorylation | QHFYQMPTPDPLVPS HCCCCCCCCCCCCCC | 34.67 | 20068231 | |
| 572 | Phosphorylation | TPDPLVPSKPMEDRI CCCCCCCCCCHHHHH | 41.74 | 20068231 | |
| 635 | Phosphorylation | FLPPQLPSDKFKDDP CCCCCCCCCCCCCCC | 63.12 | - | |
| 687 | Phosphorylation | QCLSAIASDAEQEPK HHHHHHHCCCHHCCC | 31.10 | 25159151 | |
| 698 | Phosphorylation | QEPKIDPYAFVEGDE HCCCCCCCCEECCCC | 14.66 | 27642862 | |
| 712 | Acetylation | EEFLFPDKKDRQNSE CCCCCCCHHHCCCCH | 57.73 | 23236377 | |
| 733 | Phosphorylation | HKVEDGTSSVTVLSH EECCCCCCCEEEECC | 28.48 | 29759185 | |
| 734 | Phosphorylation | KVEDGTSSVTVLSHE ECCCCCCCEEEECCH | 22.96 | 29759185 | |
| 736 | Phosphorylation | EDGTSSVTVLSHEED CCCCCCEEEECCHHH | 20.06 | 29759185 | |
| 739 | Phosphorylation | TSSVTVLSHEEDAMS CCCEEEECCHHHHHH | 25.23 | 29759185 | |
| 749 | Phosphorylation | EDAMSLFSPSIKQDA HHHHHHHCCCCCCCC | 24.03 | 17192257 | |
| 815 | Ubiquitination | KASCKESKTGNLDPL CHHHHHCCCCCCCCC | 62.64 | - | |
| 816 | Phosphorylation | ASCKESKTGNLDPLS HHHHHCCCCCCCCCC | 40.35 | 23186163 | |
| 823 | Phosphorylation | TGNLDPLSCISTADL CCCCCCCCCEEHHHH | 18.13 | 23186163 | |
| 826 | Phosphorylation | LDPLSCISTADLHKM CCCCCCEEHHHHHHH | 23.13 | 25159151 | |
| 827 | Phosphorylation | DPLSCISTADLHKMY CCCCCEEHHHHHHHC | 12.32 | 23186163 | |
| 834 | Phosphorylation | TADLHKMYPTPPSLE HHHHHHHCCCCCCHH | 14.57 | 20068231 | |
| 836 | Phosphorylation | DLHKMYPTPPSLEQH HHHHHCCCCCCHHHH | 30.28 | 20068231 | |
| 839 | Phosphorylation | KMYPTPPSLEQHIMG HHCCCCCCHHHHHCC | 45.82 | 22496350 | |
| 848 | Phosphorylation | EQHIMGFSPMNMNNK HHHHCCCCCCCCCCC | 19.94 | 20068231 | |
| 857 | Phosphorylation | MNMNNKEYGSMDTTP CCCCCCCCCCCCCCC | 18.99 | 25627689 | |
| 859 | Phosphorylation | MNNKEYGSMDTTPGG CCCCCCCCCCCCCCC | 16.75 | 25627689 | |
| 862 | Phosphorylation | KEYGSMDTTPGGTVL CCCCCCCCCCCCEEE | 26.67 | 25159151 | |
| 863 | Phosphorylation | EYGSMDTTPGGTVLE CCCCCCCCCCCEEEE | 18.70 | 17192257 | |
| 867 | Phosphorylation | MDTTPGGTVLEGNSS CCCCCCCEEEECCCC | 28.03 | 28348404 | |
| 890 | Phosphorylation | EVDEGFCSPKPSEIK EECCCCCCCCHHHCC | 33.43 | 29255136 | |
| 892 | Ubiquitination | DEGFCSPKPSEIKDF CCCCCCCCHHHCCCC | 44.90 | - | |
| 894 | Phosphorylation | GFCSPKPSEIKDFSY CCCCCCHHHCCCCCE | 59.07 | 30266825 | |
| 901 | Phosphorylation | SEIKDFSYVYKPENC HHCCCCCEEECCCCC | 14.06 | 22210691 | |
| 1005 | Phosphorylation | AGILPSPSTPRFPTP CCCCCCCCCCCCCCC | 56.21 | 21406692 | |
| 1006 | Phosphorylation | GILPSPSTPRFPTPR CCCCCCCCCCCCCCC | 23.13 | 21406692 | |
| 1011 | Phosphorylation | PSTPRFPTPRTPRTP CCCCCCCCCCCCCCC | 23.77 | - | |
| 1014 | Phosphorylation | PRFPTPRTPRTPRTP CCCCCCCCCCCCCCC | 20.51 | - | |
| 1017 | Phosphorylation | PTPRTPRTPRTPRGA CCCCCCCCCCCCCCC | 20.51 | 28985074 | |
| 1020 | Phosphorylation | RTPRTPRTPRGAGGP CCCCCCCCCCCCCCC | 20.67 | 20068231 | |
| 1022 | Methylation | PRTPRTPRGAGGPAS CCCCCCCCCCCCCCC | 47.16 | 115389153 | |
| 1029 | Phosphorylation | RGAGGPASAQGSVKY CCCCCCCCCCCCEEE | 25.02 | 30266825 | |
| 1033 | Phosphorylation | GPASAQGSVKYENSD CCCCCCCCEEECCCC | 11.89 | 30266825 | |
| 1042 | Phosphorylation | KYENSDLYSPASTPS EECCCCCCCCCCCCC | 20.00 | 27732954 | |
| 1043 | Phosphorylation | YENSDLYSPASTPST ECCCCCCCCCCCCCC | 22.68 | 27732954 | |
| 1046 | Phosphorylation | SDLYSPASTPSTCRP CCCCCCCCCCCCCCC | 44.21 | 27732954 | |
| 1047 | Phosphorylation | DLYSPASTPSTCRPL CCCCCCCCCCCCCCC | 24.30 | 27732954 | |
| 1049 | Phosphorylation | YSPASTPSTCRPLNS CCCCCCCCCCCCCCC | 39.98 | 27732954 | |
| 1050 | Phosphorylation | SPASTPSTCRPLNSV CCCCCCCCCCCCCCC | 17.46 | 27732954 | |
| 1133 | Sumoylation | FSAVMNRKFGNNSGL HHHHHCCCCCCCCCC | 53.25 | - | |
| 1138 | Phosphorylation | NRKFGNNSGLFLEDE CCCCCCCCCCCEECH | 40.65 | - | |
| 1157 | Sumoylation | GRNTDCGKEAEKRFE CCCCCCCHHHHHHHH | 61.14 | - | |
| 1247 | Phosphorylation | RQFMDNMSGGKVDEA HHHHHHCCCCCCCHH | 51.12 | - | |
| 1363 | Phosphorylation | ERLMLEPYGSQRDIA HHHCCCCCCCCCCEE | 21.75 | 29083192 | |
| 1365 | Phosphorylation | LMLEPYGSQRDIAYV HCCCCCCCCCCEEEE | 19.05 | 29083192 | |
| 1387 | Phosphorylation | ALLNGAKSFFRDLTA HHHHHHHHHHHHHHH | 29.14 | 24719451 | |
| 1393 | Phosphorylation | KSFFRDLTAIYESCR HHHHHHHHHHHHHHC | 18.46 | 20736484 | |
| 1396 | Phosphorylation | FRDLTAIYESCRLGQ HHHHHHHHHHHCCCC | 10.18 | 20736484 | |
| 1421 | Phosphorylation | GIMRVGSTASKKLSE CCHHCCCHHHHHHHH | 29.08 | - | |
| 1423 | Phosphorylation | MRVGSTASKKLSEKL HHCCCHHHHHHHHHH | 30.34 | - | |
| 1448 | Ubiquitination | GNNEAFSKLKLYAQV CCCHHHHHHHHHHHH | 43.09 | 21906983 | |
| 1452 | Phosphorylation | AFSKLKLYAQVCRYD HHHHHHHHHHHHCCC | 8.06 | 20068231 | |
| 1634 | Phosphorylation | DGDSHAVTYPPAIVV CCCCCCCCCCCEEEE | 30.97 | - | |
| 1683 | Phosphorylation | TLPPHIKSTVSVQII HCCCCCCCCEEEEEE | 33.18 | - | |
| 1684 | Phosphorylation | LPPHIKSTVSVQIIP CCCCCCCCEEEEEEE | 16.29 | - | |
| 1686 | Phosphorylation | PHIKSTVSVQIIPCQ CCCCCCEEEEEEECC | 14.37 | - | |
| 1694 | Phosphorylation | VQIIPCQYLLQPVKH EEEEECCHHHCCCCC | 18.98 | - | |
| 1728 | Phosphorylation | QCRRPLPTSTNVKTL CCCCCCCCCCCCEEC | 56.73 | 20068231 | |
| 1729 | Phosphorylation | CRRPLPTSTNVKTLT CCCCCCCCCCCEECC | 18.95 | 22210691 | |
| 1730 | Phosphorylation | RRPLPTSTNVKTLTG CCCCCCCCCCEECCC | 46.65 | 20068231 | |
| 1736 | Phosphorylation | STNVKTLTGFGPGLA CCCCEECCCCCCCHH | 35.38 | 22210691 | |
| 1746 | Phosphorylation | GPGLAMETALRSPDR CCCHHHHHHHHCCCC | 20.22 | 25159151 | |
| 1750 | Phosphorylation | AMETALRSPDRPECI HHHHHHHCCCCCHHH | 31.81 | 25159151 | |
| 1772 | Ubiquitination | ILAPVKDKQTELGET EEEECCCCCCHHHHH | 54.09 | - | |
| 1786 | Ubiquitination | TFGEAGQKYNVLFVG HHHHHHHHEEEEEEE | 37.56 | - | |
| 1833 | Phosphorylation | NRARRKKSSARKFGL CHHHHHHHHHHHHHH | 32.06 | 24260401 | |
| 1834 | Phosphorylation | RARRKKSSARKFGLQ HHHHHHHHHHHHHHH | 40.76 | 24260401 | |
| 1837 | Acetylation | RKKSSARKFGLQKLW HHHHHHHHHHHHHHH | 43.42 | 30593069 | |
| 1842 | Acetylation | ARKFGLQKLWEWCLG HHHHHHHHHHHHHHH | 61.69 | 30593075 | |
| 1887 | Phosphorylation | LSRRNLQSLSKRLKD HCHHHHHHHHHHHHH | 37.46 | 21815630 | |
| 1889 | Phosphorylation | RRNLQSLSKRLKDMC HHHHHHHHHHHHHHH | 22.45 | 23401153 | |
| 1890 | Ubiquitination | RNLQSLSKRLKDMCR HHHHHHHHHHHHHHH | 68.02 | - | |
| 2018 | Phosphorylation | IINILPASPTGSPVH HHEECCCCCCCCCCC | 22.51 | 26074081 | |
| 2020 | Phosphorylation | NILPASPTGSPVHSP EECCCCCCCCCCCCC | 48.04 | 26074081 | |
| 2022 | Phosphorylation | LPASPTGSPVHSPGS CCCCCCCCCCCCCCC | 26.65 | 26074081 | |
| 2026 | Phosphorylation | PTGSPVHSPGSHYPH CCCCCCCCCCCCCCC | 31.06 | 26074081 | |
| 2029 | Phosphorylation | SPVHSPGSHYPHGGD CCCCCCCCCCCCCCC | 24.19 | 26074081 | |
| 2031 | Phosphorylation | VHSPGSHYPHGGDAG CCCCCCCCCCCCCCC | 9.91 | 26074081 | |
| 2042 | Phosphorylation | GDAGKGQSTDRLLST CCCCCCCCCCCCCCC | 40.73 | 28450419 | |
| 2043 | Phosphorylation | DAGKGQSTDRLLSTE CCCCCCCCCCCCCCC | 19.76 | 25627689 | |
| 2048 | Phosphorylation | QSTDRLLSTEPHEEV CCCCCCCCCCCCCCC | 35.00 | 27273156 | |
| 2049 | Phosphorylation | STDRLLSTEPHEEVP CCCCCCCCCCCCCCC | 54.21 | 28450419 | |
| 2067 | Phosphorylation | QQPLALGYFVSTAKA HCCHHHCHHHHCCCC | 11.14 | 23186163 | |
| 2070 | Phosphorylation | LALGYFVSTAKAGPL HHHCHHHHCCCCCCC | 16.85 | 23186163 | |
| 2071 | Phosphorylation | ALGYFVSTAKAGPLP HHCHHHHCCCCCCCC | 27.20 | 23186163 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MED13_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MED13_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MED29_HUMAN | MED29 | physical | 22939629 | |
| MED24_HUMAN | MED24 | physical | 22939629 | |
| MED4_HUMAN | MED4 | physical | 22939629 | |
| MED14_HUMAN | MED14 | physical | 22939629 | |
| MED16_HUMAN | MED16 | physical | 22939629 | |
| MED21_HUMAN | MED21 | physical | 22939629 | |
| MED1_HUMAN | MED1 | physical | 23563140 | |
| MED26_HUMAN | MED26 | physical | 23563140 | |
| MED19_HUMAN | MED19 | physical | 23563140 | |
| MED7_HUMAN | MED7 | physical | 23563140 | |
| U5S1_HUMAN | EFTUD2 | physical | 26344197 | |
| MED1_HUMAN | MED1 | physical | 26344197 | |
| MED10_HUMAN | MED10 | physical | 26344197 | |
| MED14_HUMAN | MED14 | physical | 26344197 | |
| MED16_HUMAN | MED16 | physical | 26344197 | |
| MED18_HUMAN | MED18 | physical | 26344197 | |
| MED19_HUMAN | MED19 | physical | 26344197 | |
| MED27_HUMAN | MED27 | physical | 26344197 | |
| MED6_HUMAN | MED6 | physical | 26344197 | |
| MED8_HUMAN | MED8 | physical | 26344197 | |
| RBP2_HUMAN | RANBP2 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-326; THR-329; TYR-394;SER-395; SER-481; SER-530; SER-537; SER-890; SER-1029 AND SER-2048,AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-504; THR-519 ANDSER-537, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-326; THR-336; SER-481;SER-500; THR-863; SER-890 AND SER-1029, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-890, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029, AND MASSSPECTROMETRY. | |